ライフサイエンスコーパス: whole-body imaging

1 nanonap radiolabelling allowed complementary whole-body imaging.

2 penetrate tissue well, IFPs are suitable for whole-body imaging.

3 n and regression of xenografts visualized by whole-body imaging.

4 s visualized directly by gamma-scintigraphic whole-body imaging.

5 entative of clinical studies, in particular, whole-body imaging.

6 after kanamycin treatment were visualized by whole-body imaging.

7 ct after gavage was followed in real-time by whole-body imaging.

8 nearly over a 10-day period as determined by whole-body imaging.

9 nsitivity of the clinical PET/CT scanner for whole-body imaging.

10 olated tissues and cells and to non-invasive whole-body imaging.

11 d distribution of body fat was assessed from whole-body imaging.

12 amples of these technologic advances include whole-body imaging, 3-dimensional imaging, new scintilla

13 differences in tissue types in, for example, whole-body imaging, a set of tissue homogenates of diffe

14 To address this, we impute whole-body imaging adiposity phenotypes in UK Biobank fr

15 es transgenic (luciferase) reporter mice and whole-body imaging, allowing noninvasive quantification

16 alization of human tumor-host interaction by whole-body imaging and at the cellular level in fresh an

17 ing visualizes the tumor-host interaction by whole-body imaging and at the cellular level in fresh ti

18 Serial whole-body imaging and blood sampling were performed up

19 Planar whole-body imaging and SPECT/CT were performed from thor

20 vital two-photon microscopy and non-invasive whole-body imaging, and can be used to study microbial c

21 Tumors are tracked in living mice by whole-body imaging, and macrometastases or micrometastas

22 ion of a top-down approach using noninvasive whole-body imaging as a guide for in-depth characterizat

23 For whole-body imaging, as a measure of radiation exposure t

24 (18)F-MFBG intravenously followed by serial whole-body imaging at 0.5-1, 1-2, and 3-4 after injectio

25 loped, but their limited diffusion precludes whole-body imaging at visceral sites.

26 the course of treatment, noninvasive optical whole-body imaging based on brilliant red fluorescent pr

27 (PSMA(TV50)), SUV(max), SUV(mean), and other whole-body imaging biomarkers were calculated for each p

28 Application Domain, Semisupervised Learning, Whole-Body Imaging(C) RSNA, 2022.

29 rior petrosal sinus sampling, and adrenal or whole-body imaging can help identify tumor sources of hy

30 les from involved organs is an obstacle that whole-body imaging can help overcome.

31 Whole-body imaging can provide information across lesion

32 Skeletal-Axial, Spine, Hematologic Diseases, Whole-Body Imaging, Comparative Studies Supplemental mat

33 We used RIA, whole body imaging, flow cytometry, and fluorescence imm

34 the heart for 10 min, followed by sequential whole-body imaging for 5 h.

35 These results show the potential use of whole-body imaging for receptor status assessment, parti

36 PET whole body imaging in cancer provides the means to (i) i

37 A method based on repeated whole-body imaging in combination with blood and urinary

38 Early whole-body imaging in conjunction with delayed whole-bod

39 iagnostic sensitivities of (123)I and (131)I whole-body imaging in differentiated thyroid cancer.

40 infection can be visualized by noninvasive, whole-body imaging in mice with human immune cells over

41 Whole-body imaging indicated greater nicotine retention

42 of HCC recurrence support performing regular whole-body imaging initially every 6 to 12 months and co

43 sion-Weighted Imaging, Radionuclide Therapy, Whole-Body Imaging, Metastases, Tumor Response, Treatmen

44 Whole-body imaging might be a solution to map HER2 expre

45 (18)F-FDG PET is a molecular whole-body imaging modality that is increasingly being u

46 Brighter, red-shifted proteins can make whole-body imaging more sensitive owing to reduced absor

47 For whole-body imaging, nude mice are very appropriate.

48 periments; demonstrated here is MALDI-IMS-MS whole body imaging of rats dosed at 6 mg/kg i.v. with an

49 -ray computed tomography allows quantitative whole-body imaging of (111)In-oxine-labeled CTLs at tumo

50 Whole-body imaging of 12 patients, who received 111-185

51 first time with the 3D topographic MS-based whole-body imaging of a mouse.

52 -CD8alpha antibody ((89)ZED88082A) to enable whole-body imaging of CD8(+) T-cells through positron em

53 With the exception of liver metastases, whole-body imaging of ER expression with (18)F-FES PET c

54 ein-based imaging technology can be used for whole-body imaging of fluorescent cells on essentially a

55 s, we demonstrated the utility of HYBRiD for whole-body imaging of genetically encoded fluorescent re

56 nal cutaneous recurrence (TxN2bM0) underwent whole-body imaging of glucose metabolism with fluorodeox

57 VEGFR3 to engineer mouse melanoma models for whole-body imaging of metastasis generated by human cell

58 ation burden for future studies was based on whole-body imaging of monkeys.

59 protein offers the potential for noninvasive whole-body imaging of numerous cellular and molecular pr

60 Whole-body imaging of rhesus monkeys showed high uptake

61 It allows noninvasive, whole-body imaging of the FR.

62 Noninvasive whole-body imaging of the immune status of individual pa

63 Real-time whole-body imaging of the live animals confirmed improve

64 "stick objectives"), is used for three-color whole-body imaging of the two-color cancer cells interac

65 raphy (PET) reporter genes allow noninvasive whole-body imaging of transplanted cells by detection wi

66 aken advantage of to develop a technology of whole-body imaging of tumors and gene expression in mous

67 All patients underwent whole-body imaging on a PET/CT device 1 h after (18)F-FD

68 Healthy volunteers underwent serial whole-body imaging over an approximately 3-h interval, a

69 On whole-body imaging, P-gp blockade significantly affected

70 Using fluorescence whole body imaging, polymerase-chain reaction (PCR) and

71 cessing electronics to enable an inexpensive whole-body imaging probe.

72 nidae and Limacidae, and describe an in vivo whole-body imaging procedure for invertebrate species.

73 ng technique, PSMA PET represents a reliable whole-body imaging procedure in combination with second-

74 y ICI response than (18)F-FDG with favorable whole-body imaging properties.

75 l isotope distribution using (18)F-FDG and a whole-body imaging protocol to demonstrate proof-of-prin

76 esity, Metabolic Disorders, Volume Analysis, Whole-Body Imaging, Quantification, Supervised Learning,

77 Whole-body imaging revealed that the cells retained thei

78 vaccination and allogeneic graft rejection, whole body imaging reveals that RA signaling is temporal

79 in as an optimal combination for dual color, whole body imaging studies in model animals.

80 weighted Imaging, Neural Networks, Oncology, Whole-Body Imaging, Supervised Learning, MR-Functional I

81 n-weighted MRI, Pediatric, Sarcoma, Staging, Whole-Body Imaging Supplemental material is available fo

82 rescent protein-transfected cancer cells and whole-body imaging system.

83 Positron emission tomography (PET) is a whole-body imaging technique using 18 fluorine-fluorodeo

84 r below the detection limits of conventional whole body imaging techniques.

85 Whole-body imaging techniques play a vital role in explo

86 tection/Diagnosis, Lymphoma, Tumor Response, Whole-Body Imaging, Technology AssessmentClinical trial

87 quantification of PD-L1 through noninvasive whole-body imaging, thereby enhancing patient stratifica

88 Here, we use whole-body imaging to determine the efficacy and kinetic

89 nical applications, enabling the noninvasive whole-body imaging to localize disease and identificatio

90 tigraphy but was obvious on post-therapeutic whole-body imaging, underscoring the value of post-thera

91 Whole-body imaging was carried out with either a trans-i

92 fter a period of thyroid hormone withdrawal, whole-body imaging was performed approximately 24 and 72

93 Planar whole-body imaging was performed at 2 and 24 h after inj

94 formed on healthy volunteers, and sequential whole-body imaging was performed over 4 h.

95 of (18)F-FDG were administered and repeated whole-body imaging was performed.

96 vital and confocal microscopy, together with whole-body imaging, we measured tumor growth delay, surv

97 naive CD4 T-cell precursor enumeration, and whole-body imaging, we report that DO affects the repert

98 In, for example, whole-body imaging where a diversity of tissue types are

99 etic resonance (MR) imaging and fluorescence whole body imaging, which respectively tracked iron oxid

100 tion and biological behavior of NIR-II dyes, whole body imaging with NIR-II dyes for cancer detection

101 Forty patients underwent baseline whole-body imaging with 99mTc-sulfur colloid and evaluat

102 ging of non-small cell lung cancer underwent whole-body imaging with a sequential trimodality PET/CT/

103 estaging of oncologic malignancies underwent whole-body imaging with a sequential trimodality PET/CT/

104 Whole-body imaging with contrast-enhanced CT can be used

105 Whole-body imaging with fluorescent proteins is a powerf

106 (18)F-FDG PET/CT scans (whole-body imaging with low-dose CT) of 24 consecutive p

107 ality imaging could provide both noninvasive whole-body imaging with organ-level biodistribution and

108 ase I study of 62Cu-PTSM was performed using whole-body imaging with PET in 10 healthy volunteers and

109 Whole-body imaging, with scintimammography and PET, and